Contineum Therapeutics, Inc. · NASDAQ:CTNM

Lorrain Daniel S. sold 4,170 Contineum Therapeutics, Inc. shares (Form 4)

Traded May 1, 2026 · Filed May 1, 2026

On May 1, 2026, Lorrain Daniel S. (Chief Scientific Officer) sold 4,170 Contineum Therapeutics, Inc. shares at an average US$13.12 for US$54,694 under a trading plan, leaving 143,542 shares. Filed May 1, 2026 (Form 4).

Sold
4,170 shares
Price
US$13.12 average (US$13.06 to US$13.84)
Value
US$54,694
Holding after
143,542 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 1, 2026Class A Common StockSale3,870US$13.06143,842Direct
May 1, 2026Class A Common StockSale300US$13.84143,542Direct

Source

View original at SEC

Related